Purchase Order SPE2DP25V3407
Award Date 8/19/25
Potential Completion Date 10/27/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Brooklyn, NY 11207, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, SPE2DP24P0065, was issued by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The $2,117.75 firm-fixed-price purchase order is for the delivery of moxifloxacin hydrochloride, a pharmaceutical product, with a completion date of November 13, 2023. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. This award is not...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a firm fixed-price purchase order valued at $1,809.47 to SZY Holdings, LLC for Nirmatrelvir and related pharmaceutical supplies. The contract, issued on August 22, 2025, with an ultimate completion date of October 30, 2025, represents a direct procurement with no small business set-aside designation. SZY Holdings, a for-profit limited liability company headquartered in Brooklyn, New York, will perform the work at its...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a $2,045 firm-fixed-price purchase order to SZY Holdings, LLC for magnesium sulfate, with an ultimate completion date of November 10, 2025. SZY Holdings, a Brooklyn-based manufacturer of medical equipment and supplies, was selected without a set-aside designation. The contract was awarded on August 27, 2025, and performance will occur in Brooklyn, New York. This purchase order represents a continuation of the DLA's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a $1,840 firm fixed-price purchase order to SZY Holdings, LLC for Nirmatrelvir and Ritonavir (an antiviral pharmaceutical treatment) on March 12, 2025. The contract, which carries no set-aside designation, is scheduled for completion by May 20, 2025, with performance taking place at the vendor's facility in Brooklyn, New York. SZY Holdings, a for-profit limited liability company and registered small business, will...
- This is a $1,014 firm-fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract is for the delivery of ARTEMETHER-LUMEFANT medical supplies, with a completion date of August 14, 2025. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. This award does not have a set-aside designation. SZY Holdings has been...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract, valued at $1,310.64, is for the delivery of MOXIFLOXACIN HYDROC, a pharmaceutical product, with a completion date of May 19, 2023. SZY Holdings, a manufacturer of medical equipment, supplies, and consumables, has a strong track record of securing federal contracts with the DLA, including an Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price purchase order to SZY Holdings, LLC for Albendazole tablets, with a ceiling value of $3,587.95 and an ultimate completion date of October 20, 2025. This contract, awarded on August 14, 2025, carries no set-aside designation. SZY Holdings, a Brooklyn, New York-based manufacturer of medical equipment and supplies with continuous federal registration since 2006, will perform the work at its Brooklyn...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $8,590.08 firm fixed-price purchase order to SZY Holdings, LLC on May 9, 2025, for the procurement of Moxifloxacin Hydrochloride, an antibiotic pharmaceutical used in military and federal healthcare programs. This standard purchase order, which carries no set-aside designation, is scheduled for completion by July 14, 2025, with performance taking place at the contractor's facility in Brooklyn, New York. The award supports the...
- This is a firm-fixed-price purchase order awarded by the Defense Logistics Agency's Medical Supply Chain division to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract, valued at $2,902.62, is for the delivery of MOXIFLOXACIN HYDROC (8510390403), a pharmaceutical product, with a completion date of February 20, 2024. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. The...
- SZY Holdings, LLC, doing business as SZY Holdings LLC, has been awarded a purchase order contract valued at one hundred twenty-four thousand eight dollars ($124,008) by the Defense Logistics Agency Troop Support Medical to deliver levofloxacin tablets. The prime contractor will provide the pharmaceutical products to the Department of Defense logistics agency from its place of performance in Brooklyn, New York. With a start date of September 6, 2023 and end date of September 26, 2023, SZY...